Improved transduction of primary murine hepatocytes by recombinant adeno-associated virus 2 vectors in vivo

Gene Therapy

Volumn 11, Issue 14, 2004, Pages 1165-1169

  Zhong, L ^a   Li, W ^a   Yang, Z ^a   Chen, L ^a   Li, Y ^a   Qing, K ^a,b   Weigel Kelley, K A ^a   Yoder, M C ^a   Shou, W ^a   Srivastava, A ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

AAV vectors; Gene expression; Gene transfer; Liver cells

Indexed keywords

FK 506 BINDING PROTEIN; PARVOVIRUS VECTOR; PROTEIN TYROSINE PHOSPHATASE; SINGLE STRANDED DNA; DNA; T CELL PROTEIN TYROSINE PHOSPHATASE; T-CELL PROTEIN TYROSINE PHOSPHATASE; TACROLIMUS BINDING PROTEIN 4;

ARTICLE; CATALYSIS; CELL BASED GENE THERAPY; CYSTIC FIBROSIS; DNA STRAND; DNA SYNTHESIS; DOCUMENTATION; DRUG MECHANISM; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE TARGETING; GENETIC TRANSDUCTION; HEMOPHILIA B; HUMAN; IN VIVO STUDY; KNOCKOUT MOUSE; LIVER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN DEPHOSPHORYLATION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RODENT; T LYMPHOCYTE; TRANSGENE; TRANSGENIC MOUSE; VIRAL GENE THERAPY; VIRUS CAPSID; VIRUS RECOMBINANT; ADENO ASSOCIATED VIRUS; ANIMAL; BIOSYNTHESIS; GENE THERAPY; GENE VECTOR; GENETICS; METABOLISM; METHODOLOGY; MOUSE; MOUSE MUTANT;

ADENO-ASSOCIATED VIRUS; ADENO-ASSOCIATED VIRUS 2; MURINAE; MUS MUSCULUS;

ANIMALS; DEPENDOVIRUS; DNA; GENE EXPRESSION REGULATION; GENE THERAPY; GENETIC VECTORS; HEPATOCYTES; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; PROTEIN-TYROSINE-PHOSPHATASE; TACROLIMUS BINDING PROTEINS; TRANSDUCTION, GENETIC;

EID: 4344618802     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3302283     Document Type: Article

References (29)

1. Muzyczka N, Berns KI. In: Knipe D, Howley P, Griffin D, Lamb R, Martin M, Roizman B, Straus S (eds). Fields Virology, Vol. 2 Lippincott, Williams & Wilkins: Philadelphia, PA, 2001, pp 2327-2347.
2. Nakai H, Storm TA, Kay MA. Recruitment of single-stranded recombinant adeno-associated virus vector genomes and intermolecular recombination are responsible for stable transduction of liver in vivo. J Viral 2000; 74: 9451-9463.
3. Chen ZY et al. Linear DNAs concatemerize in vivo and result in sustained transgene expression in mouse liver. Mol Ther 2001; 3: 403-410.
4. Fisher KJ et al. Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis. J Virol 1996; 70: 520-532.
5. Ferrari FK, Samulski T, Shenk T, Samulski RJ. Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors. J Viral 1996; 70: 3227-3234.
6. Mah C et al. Adeno-associated virus 2-mediated gene transfer: role of epidermal growth factor receptor protein tyrosine kinase in transgene expression. J Viral 1998; 72: 9835-9841.
7. Qing KY et al. Adeno-associated virus type 2-mediated gene transfer: correlation of tyrosine phosphorylation of the cellular single-stranded D sequence-binding protein with transgene expression in human cells in vitro and murine tissues in vivo. J Virol 72; 1998: 1593-1599.
8. Qing KY et al. Adeno-associated virus type 2-mediated gene transfer: role of cellular FKBP52 protein in transgene expression. J Virol 2001; 75: 8968-8976.
9. Qing KY et al. Adeno-associated virus type 2-mediated gene transfer: role of cellular T-cell protein tyrosine phosphatase in transgene expression in established cell lines in vitro and transgenic mice in vivo. J Viral 2003; 77: 2741-2746.
10. Qing KY et al. Role of tyrosine phosphorylation of a cellular protein in adeno-associated virus 2-mediated transgene expression. Proc Natl Acad Sci USA 1997; 94: 10879-10884.
11. Wang X-S, Qing KY, Ponnazhagan S, Srivastava A. Adeno-associated virus type 2 DNA replication in vivo: mutation analyses of the D sequence in viral inverted terminal repeats. J Virol 1997; 71: 3077-3082.
12. Ponnazhagan S et al. Adeno-associated virus 2-mediated gene transfer in vivo: organ-tropism and expression of transduced sequences in mice. Gene 1997; 190: 203-210.
13. Snyder RO et al. Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors. Nat Genet 1997; 16: 270-276.
14. Nakai H, Storm TA, Kay MA. Increasing the size of rAAV-mediated expression cassettes in vivo by intermolecular joining of two complementary vectors. Nat Biotechnol 2000; 18: 527-532.
15. Chen SF, Tazelaar J, Wilson JM. Selective repopulation of normal mouse liver by hepatocytes transduced in vivo with recombinant adeno-associated virus. Hum Gene Ther 2001; 12: 45-50.
16. Song S et al. Stable therapeutic serum levels of human α1 antitrypsin (AAT) after portal vein injection of recombinant adeno-associated virus (rAAV) vectors. Gene Therapy 2001; 8: 1299-1306.
17. Miao CH et al. The kinetics of rAAV integration in the liver. Nat Genet 1998; 19: 13-15.
18. Miao CH et al. Nonrandom transduction of recombinant adeno-associated virus vectors in mouse hepatocytes in vivo: cell cycling does not influence hepatocyte transduction. J Virol 2000; 74: 3793-3803.
19. Nakai H et al. A limited number of transducible hepatocytes restricts a wide-range linear vector dose response in recombinant adeno-associated virus-mediated liver transduction. J Virol 2002; 76: 11343-11349.
20. Czar MJ et al. Evidence that the FK506-binding protein 56 is required for trafficking of the glucocorticoid receptor from the cytoplasm to the nucleus. Mol Endocrinol 1995; 9: 1549-1560.
21. Miyata Y et al. Phosphorylation of the immunosuppresant FK506-binding protein FKBP52 by casein kinase II: regulation of HSP90-binding, activity of FKBP52. Proc Natl Acad Sci USA 1997; 94: 14500-14505.
22. Lorenzen JA, Dadabay CY, Fischer EH. COOH-terminal sequence motifs target the T cell protein tyrosine phosphatase to the ER and nucleus. J Biol Chem 1995; 131: 631-643.
23. You-Ten KE et al. Impaired bone marrow microenvironment and immune function in T cell protein tyrosine phosphatase-deficient mice. J Exp Med 1997; 186: 683-693.
24. Muise ES et al. Thermosensitive mutants of the MPTP and hPTP1B protein tyrosine phosphatases: isolation and structural analysis. Protein Sci 1996; 5: 604-613.
25. Hansen J et al. Impaired intracellular trafficking of adeno-associated virus type 2 vectors limits efficient transduction of murine fibroblasts. J Virol 2000; 74: 992-997.
26. Hansen J, Qing KY, Srivastava A. Infection of purified nuclei by adeno-associated virus. Mol Ther 2001; 4: 289-296.
27. McCarty DM, Monahan PE, Samulski RJ. Self-complementary recombinant adeno-associated virus (scAAV) vectors promote efficient transduction independently of DNA synthesis. Gene Therapy 2001; 8: 1248-1254.
28. Wang Z et al. Rapid and highly efficient transduction by double-stranded adeno-associated virus vectors in vitro and in vivo. Gene Therapy 2003; 10: 2105-2111.
29. McCarty DM et al. Adeno-associated virus terminal repeat (TR) mutant generates self-complementary vectors to overcome the rate-limiting step to transduction in vivo. Gene Therapy 2003; 10: 2112-2118.